在较晚的年龄段,全源性造血干细胞移植的可行性
Sara Fernandez-Luis1, David Gomez Lamas2, Juan Manuel Cerezo Martin3
1Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain. Sara.fernandezl@scsalud.es.
Annals of hematology
|November 4, 2023
概括
年长的成年人可以安全地接受全原干细胞移植 (allo-HSCT) 以个性化护理. 患者选择和量身定制的程序确保有效的结果,即使对于70岁以上的人.
科学领域:
- 血液学 血液学 血液学
- 移植免疫学 移植免疫学
- 老年医学 老年医学
背景情况:
- 年龄的增加与异性干细胞移植 (allo-HSCT) 的更高风险有关.
- 个性化方法可能使老年患者能够接受allo-HSCT.
- 这项研究调查了60岁以上患者的结局.
研究的目的:
- 评估60岁及以上患者的alo-HSCT的安全性和疗效.
- 为了比较不同年龄小组 (60-64岁,65-69岁,≥70岁) 和训练强度的结果.
主要方法:
- 对97名60岁以上的患者进行了回顾性分析,这些患者接受了首次allo-HSCT (2011-2019).
- 收集关于诊断,调节方案,生存率,复发和非复发死亡率的数据.
- 统计分析以比较年龄组和条件强度之间的结果.
主要成果:
- 在3年随访时,总生存率为50%,无进展生存率为46%.
- 复发的累积发病率为22%,非复发死亡率为32%.
- 在年龄组 (60-64岁,65-69岁,≥70岁) 或条件强度之间没有发现生存,复发或死亡率的显著差异.
结论:
- 老年人可以安全有效地接受allo-HSCT.
- 适当的患者选择和个性化的移植方案对于老年患者的成功结果至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
339
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
339
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Tissue Transplantation
376
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
376
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


